机器人辅助Warshaw手术101例临床疗效与学习曲线分析
该回顾性病例系列分析了101例机器人辅助Warshaw手术患者,评估其临床疗效与学习曲线。结果显示手术安全可行,手术时间和出血量的熟练点分别在45例和39例,并发症学习曲线拐点为60例, textbook outcome掌握需85例。
要点
- 机器人辅助Warshaw手术安全可行,保脾成功率90.10%。
- 手术时间与出血量学习曲线拐点分别为45例和39例。
- 术后并发症与textbook outcome学习曲线拐点分别为60例和85例。
核心结论
- 机器人辅助Warshaw手术安全可行,学习曲线呈现阶段式进步。
研究设计与样本
- 回顾性病例系列,纳入2020年11月至2023年1月青岛大学附属医院肝胆胰外科101例连续接受机器人辅助Warshaw手术的患者。
主要发现
- 101例患者中男21例(20.79%),女80例(79.21%),平均年龄48.90±11.97岁。
- 平均手术时间187.09±52.36 min,中位出血量50 ml(IQR 20-100 ml)。
- 91例(90.10%)成功完成Warshaw手术,7例(6.93%)中转远端胰腺切除联合脾切除,3例(2.97%)中转开腹。
- 术后胰瘘18例(17.82%),其中生化漏13例(12.87%),B级瘘5例(4.95%),无C级瘘。
- 术后出血5例(4.95%),腹腔感染3例(2.97%),2例(1.98%)需再次手术。
关键数值与推荐
- 手术时间CUSUM曲线方程:CUSUM=0.003156X³-1.141X²+83.71X-1.092,R²=0.936(P<0.05),峰值在第45例。
- 出血量CUSUM曲线方程:CUSUM=0.01250X³-2.889X²+167.4X-33.65,R²=0.927(P<0.05),峰值在第39例。
- 术后并发症学习曲线拐点为第60例,textbook outcome拐点为第85例。
- 以手术时间第45例为界,熟练期手术时间、出血量和引流时间显著改善(P<0.05)。
- 以textbook outcome第85例为界,手术时间、出血量和textbook outcome达标率显著改善(P<0.05)。
临床怎么用
- 机器人辅助Warshaw手术可用于需保留脾脏的胰体尾良性或低度恶性肿瘤患者。
- 学习曲线提示术者约45例后手术时间趋于稳定,60例后并发症减少,85例后textbook outcome提高。
- 对于保脾意愿强烈的患者,可考虑在经验丰富的中心由度过学习曲线的术者实施。
局限性
- 回顾性单中心研究,可能存在选择偏倚。
- 样本量有限(101例),学习曲线分析基于单术者或团队,外推性需谨慎。
- 随访资料部分缺失(脾梗死和胃底静脉曲张分析仅62例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the clinical efficacy of robotic-assisted Warshaw procedure and analyze its learning curve. METHODS: This retrospective case series analyzed 101 consecutive patients who underwent robotic-assisted Warshaw procedure at the Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Qingdao University, between November 2020 and January 2023. Patient demographics, perioperative outcomes, pathological findings, and follow-up data were collected. For continuous variables such as operative time and blood loss, the cumulative sum (CUSUM) method and best-fit curve analysis were employed to assess the learning curve. For categorical variables including major complications and textbook outcome, a 2-piece linear model was used. Patients were stratified into early learning phase and proficiency phase groups based on the identified inflection points, and perioperative outcomes were compared between groups. RESULTS: (1) Patient demographics and perioperative outcomes: Among 101 patients (21 males [20.79%] and 80 females [79.21%], mean age 48.90 ± 11.97 years), the mean operative time was 187.09 ± 52.36 min and median blood loss was 50 ml (IQR: 20-100 ml). The Warshaw procedure was successfully completed in 91 patients (90.10%), while 7 patients (6.93%) required conversion to distal pancreatectomy with splenectomy, and 3 patients (2.97%) were converted to open surgery. Postoperative pancreatic fistula (POPF) occurred in 18 patients (17.82%), including 13 biochemical leaks (12.87%) and 5 grade B fistulas (4.95%), with no grade C fistulas. No chylous fistula or delayed gastric emptying was observed. Postoperative hemorrhage occurred in 5 patients (4.95%) and intra-abdominal infection in 3 patients (2.97%), with 2 patients (1.98%) experiencing both complications requiring reoperation. One patient (0.99%) developed bowel obstruction. The mean time to first oral intake was 2.35 ± 0.69 days. Fifty-six patients (55.44%) were discharged with drains. Median postoperative hospital stay was 6.00 days (IQR: 5.00-7.50), and mean drainage duration was 9.88 ± 2.92 days. All patients were discharged without perioperative mortality or 90 day readmission. During follow-up, 10 patients (16.13%, 10/62) developed varying degrees of splenic infarction, and 13 patients (20.96%, 13/62) developed gastric varices, but no severe complications such as splenic abscess or gastrointestinal bleeding occurred. (2) Learning curve analysis: For operative time and blood loss, CUSUM learning curves were best fitted by the equations: CUSUM(operative time) = 0.003156X3 - 1.141X2 + 83.71X - 1.092 and CUSUM(blood loss) = 0.01250X3 - 2.889X2 + 167.4X - 33.65 (where X represents case number), with R2 values of 0.936 and 0.927, respectively (P < 0.05). The CUSUM value for operative time peaked at case 45, while that for blood loss peaked at case 39. For postoperative complications, the learning curve inflection point was case 60, while for textbook outcome, it was case 85. (3) Comparison between learning phases: Using operative time (case 45) as the cutoff point, there were no significant differences in ASA scores or POPF rates between the two phases (P > 0.05). However, significant improvements were observed in operative time, blood loss, and drainage duration in the proficiency phase (P < 0.05). Using textbook outcome (case 85) as the cutoff point, significant improvements were seen in operative time, blood loss, and textbook outcome achievement (P < 0.05). CONCLUSION: (1) The robotic-assisted Warshaw procedure is safe and feasible. (2) Learning curve analysis revealed that proficiency in operative time and blood loss was achieved earlier, followed by postoperative complications (60 cases), while mastery of textbook outcomes required the most experience (85 cases).
引用
- Liu H, Hao Q, Wang X, et al. Clinical efficacy and learning curve analysis of 101 robotic-assisted Warshaw procedures: a retrospective study. Surg Endosc. 2025. PMID: 40372447. doi:10.1007/s00464-025-11790-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。